Loading…
Product type
Recombinant Human Insulin is a synthetic form of insulin produced through recombinant DNA technology. It is identical in structure to naturally occurring human insulin and is typically manufactured using genetically modified bacteria or yeast. This biotechnology-derived active pharmaceutical ingredient is crucial for the treatment of diabetes, providing patients with the necessary hormone to regulate blood sugar levels effectively.
| Purity | ≥ 95% |
| Form | Lyophilized powder or solution |
| Storage conditions | 2°C to 8°C |
| Stability | 24 months at recommended storage |
| Dosage forms | Injectable solutions, pens, or cartridges |
When selecting recombinant human insulin, buyers should consider the required purity levels and the specific formulation needed for their applications. It is important to specify the desired dosage forms and any necessary stability data. Additionally, inquire about certifications such as Good Manufacturing Practices (GMP) and relevant quality control measures. Quantities should align with production needs to ensure adequate supply.
Get quotes for Recombinant Human Insulin
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
It is primarily used for managing diabetes by regulating blood sugar levels.
It is produced using recombinant DNA technology in genetically modified microorganisms.
It should be stored at 2°C to 8°C to maintain its efficacy.
Typical purity levels are ≥ 95%.
It is available in lyophilized powder or injectable solutions.
It typically has a stability of 24 months when stored correctly.